Pircher, M; Mlineritsch, B; Fridrik, M; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Ressler, S; Rinnerthaler, G; Ulmer, H; Greil, R.
Lapatinib plus Caelyx in patients with advanced or metastatic Her 2 positive breast cancer following failure of Trastuzumab therapy - A Phase II study of the Arbeitsgemeinschaft Medikamentose Tumortherapie
ONKOLOGIE. 2013; 36: 159-159.
[Oral Communication]
Web of Science